-+ 0.00%
-+ 0.00%
-+ 0.00%

IN8BIO REPORTS CONTINUED DURABLE REMISSIONS IN PHASE 1 TRIAL OF INB-200 IN PLENARY ORAL PRESENTATION AT THE SOCIETY FOR NEURO-ONCOLOGY (SNO) ANNUAL MEETING

Reuters·11/25/2024 12:00:00

Please log in to view news